Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
Condition: Tuberculosis, Pulmonary Interventions: Drug: High-dose rifampicin; Drug: Isoniazid; Drug: Pyrazinamide; Drug: Ethambutol; Drug: Rifampicin Sponsors: Seoul National University Hospital; Chonnam National University Hospital; National Medical Center, Seoul; Pusan National University Hospital; Pusan National University Yangsan Hospital; Seoul National University Bundang Hospital; SMG-SNU Boramae Medical C enter; Severance Hospital; Korean Institute of Tuberculosis; International Tuberculosis Research Center; Korean Center for Disease Control and Prevention Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials